Global Single-use Bioreactors Market Overview:
According to SPER Market Research, the Single-use Bioreactors Market is estimated to reach USD 17.28 billion by 2030 with a CAGR of 19.8%. Escalating Biopharmaceutical research & development, growing technological advancements in SUBs, acceptance of SUBs amongst start-ups, and small companies, abridged automation difficulty, simplicity in the farming of marine organisms, condensed energy and water consumption, and the increasing biologics market; are the key factors for the expansion of the market.
Impact of COVID-19 on the Single-use Bioreactors Market
The outbreak of COVID-19, provide positive growth in this market, and big pharmaceutical and biopharmaceutical companies increased their investment in research & development, and manufacturing of vaccines and test kits in large numbers.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2019-2030 |
| Base year considered | 2021 |
| Forecast period | 2022-2030 |
| Segments covered | By Product, By Type, By Application, By type of cell, By molecule Type, By Region
|
| Geographies covered | North America, Europe, Asia Pacific, Latin America, Middle East, Africa |
| Companies Covered | ABEC, Inc., Able Corporation & Biott Corporation, Avantor, bbi-biotech GmbH, Cellexus, Cell culture company, Celltainer Biotech, CESCO Bioengineering Co. Ltd., Corning, Danaher Corporation, Distek, Inc., Entegris, Eppendorf AG, G&G Technologies, Getinge AB, Kuhner AG, Meissner Filtration Products, Inc., Merck KGaA, OmniBRx Biotechnologies, PBS Biotech, Inc., Pierre Guerin, Sartorius Stedim Biotech S.A., Satake Chemical Equipment Mfg., Ltd., Solida Biotech GmbH, Stobbe Pharma GmbH, Thermo Fisher Scientific
|
Driver: Increasing biopharmaceutical R&D
Growing geriatric population, growing acceptance of SUBs among small companies and start-ups, abridged automation difficulty, simplicity in the farming of marine organisms, reduced energy and water consumption, rising biologics market, technological advancements in SUBs, and growing biopharmaceutical research & development; are the key factors for the expansion of the market.
Challenges: necessitate of improvement single-use sensors
Improvement in single-use sensors, standardization of single-use design, Regulatory concerns related to SUBs, and Issues related to leachable and extractable; are the challenges to this market.
Opportunity: Emerging markets
The growing demands for pharmaceutical & biopharmaceutical research & development in the emerging economies offer vast opportunities.
Global Single-use Bioreactors Market Segmentation:
By Product: Based on the product, Single-use Bioreactors Market is segmented as; Single-use Bioreactor Systems (Up to 10L, 11–100L, 101–500L, 501–1500L, Above 1500L), Single-use Media Bags (2D Bags, 3D Bags, Other Bags), Single-use Filtration Assemblies, Other Products (Single-use vessels, tubing and connectors, samplers, and probes/sensor, and others).
By Type: Based on the Type, Single-use Bioreactors Market is segmented as; Bubble-column SUBs, Other SUBs (Hybrid bioreactors and SUBs with vertically perforated discs), Stirred-tank SUBs, and Wave-induced SUBs.
By Type of Cell: Based on the Type of Cell, Single-use Bioreactors Market is segmented as; Bacterial Cells, Mammalian Cells, Other Cells (Insect and plant cells), and Yeast Cells.
By Molecule Type: Based on the type of molecule, Single-use Bioreactors Market is segmented as; Gene-modified cells, Monoclonal Antibodies, and Other Molecules (Recombinant proteins including growth factors & interferon, antisense, RNA interference, and others), Stem Cells, and Vaccines.
By Application: Based on the Type of Application, Single-use Bioreactors Market is segmented as; Bio-production, Process Development, Research, and Development
By End-Users: Based on the End-Users, Single-use Bioreactors Market is segmented as; Academic & Research Institutes, Biopharmaceutical & Pharmaceutical companies, Contract Research Organizations, and contract manufacturing organizations (CROs & CMOs).
By Region: North America owns the principal share of this market; this is due to the concentration of established biopharmaceutical industries, and key players functioning in the single-use bioreactors market.
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. COVID-19 Impact on the Single-use Bioreactors Market
4.4. Market Trends
5. Global Single-use Bioreactors Market, by Product, 2019-2030 (USD Million)
5.1. Single-use Bioreactor Systems
5.1.1. Up to 10L
5.1.2. 11–100L
5.1.3. 101–500L
5.1.4. 501–1500L
5.1.5. Above 1500L
5.2. Single-use Media Bags
5.2.1. 2D Bags
5.2.2. 3D Bags
5.2.3. Other Bags
5.3. Single-use Filtration Assemblies
5.4. Other Products (Single-use vessels, tubing and connectors, samplers, probes/sensor, and others)
6. Global Single-use Bioreactors Market, by Type, 2019-2030 (USD Million)
6.1. Bubble-column SUBs
6.2. Other SUBs (Hybrid bioreactors and SUBs with vertically perforated discs)
6.3. Stirred-tank SUBs
6.4. Wave-induced SUBs
7. Global Single-use Bioreactors Market, by Type of Cell, 2019-2030 (USD Million)
7.1. Bacterial Cells
7.2. Mammalian Cells
7.3. Other Cells (Insect and plant cells)
7.4. Yeast Cells
8. Global Single-use Bioreactors Market, by Molecule Type, 2019-2030 (USD Million)
8.1. Gene-modified cells
8.2. Monoclonal Antibodies
8.3. Other Molecules (Recombinant proteins including growth factors & interferon, antisense, RNA interference and others)
8.4. Stem Cells
8.5. Vaccines
9. Global Single-use Bioreactors Market, by Application, 2019-2030 (USD Million)
9.1. Bio-production
9.2. Process Development
9.3. Research and Development (R&D)
10. Global Single-use Bioreactors Market, by End-Users, 2019-2030 (USD Million)
10.1. Academic & Research institutes
10.2. Biopharmaceutical & Pharmaceutical companies
10.3. Contract Research Organizations and contract manufacturing organizations (CROs & CMOs)
11. Global Single-use Bioreactors Market, by Region, 2019-2030 (USD Million)
11.1. North America
11.1.1. US
11.1.2. Canada
11.2. Europe
11.2.1. France
11.2.2. Germany
11.2.3. Italy
11.2.4. Rest of the Europe
11.2.5. Spain
11.3. Asia Pacific
11.3.1. China
11.3.2. India
11.3.3. Japan
11.3.4. Rest of Asia Pacific
11.4. Latin America
11.5. Middle East
11.6. Africa
12. Competitive Landscape
12.1. Introduction
12.2. Market Share Analysis, By Key Players
12.3. Competitive Scenario
12.3.1. Product Launches
12.3.2. Partnerships, Collaborations and Agreements
12.3.3. Acquisitions
12.3.4. Expansions
12.3.5. Other Developments
13. Company Profiles
13.1. ABEC, Inc.
13.2. Able Corporation & Biott Corporation
13.3. Avantor
13.4. bbi-biotech GmbH
13.5. Cellexus
13.6. Cell culture company
13.7. Celltainer Biotech
13.8. CESCO Bioengineering Co. Ltd.
13.9. Corning
13.13. Danaher Corporation
13.11. Distek, Inc.
13.12. Entegris
13.13. Eppendorf AG
13.14. G&G Technologies
13.15. Getinge AB
13.16. Kuhner AG
13.17. Meissner Filtration Products, Inc.
13.18. Merck KGaA
13.19. OmniBRx Biotechnologies
13.20. PBS Biotech, Inc.
13.21. Pierre Guerin
13.22. Sartorius Stedim Biotech S.A.
13.23. Satake Chemical Equipment Mfg., Ltd.
13.24. Solida Biotech GmbH
13.25. Stobbe Pharma GmbH
13.26. Thermo Fisher Scientific